Independent Director · Sarepta Therapeutics, Inc. (SRPT)

Michael Chambers director compensation at Sarepta Therapeutics: $544K

Fiscal year 2025 director compensation for Michael Chambers at Sarepta Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 24, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Michael Chambers’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Michael Chambers and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Sarepta Therapeutics Director Compensation Table · all 2 fiscal years held
In US dollars, as Sarepta Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$70,000$237,561$236,905$0$544,466
FY2024$68,331$237,525$248,782$0$554,638

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Sarepta Therapeutics, Inc. DEF 14A filed April 24, 2026, accession 0001193125-26-177247, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Sarepta Therapeutics, Inc. filed document, accession 0001193125-26-177247. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2026.

Get the Sarepta Therapeutics Board Governance Report

$544,466 Michael Chambers, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 24, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Sarepta Therapeutics pays directors a $60,000 cash retainer and $475,000 in RSUs/Options.

The rest of the Sarepta Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Claude NicaiseIndependent Director$554,466
Deirdre ConnellyIndependent Director$558,153
Douglas S. IngramDirector—
Hans WigzellIndependent Director$562,466
Kathryn J. BoorIndependent Director$552,466
M. Kathleen BehrensIndependent Director$603,923
Richard J. BarryIndependent Director$577,279
Stephen L. MayoIndependent Director$556,966

The full Sarepta Therapeutics compensation record

free company brief

This page is one director within Sarepta Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Sarepta Therapeutics proxy · each links to its own free brief

Order SRPT

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report